May 2026
📣 VC round data is live. Check it out!
Largest PE & VC Public Companies in Hong Kong
Benchmark revenue and EBITDA valuation multiples for public comps like
Regent Pacific Group.
 | Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Its geographical segments are China, Europe, Hong Kong, and Taiwan. | $0 | -- | $27M | $31M | 85.4x | (7.1x) | ||
| Median | $0 | -- | $27M | $31M | 85.4x | (7.1x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.